Gene SNPs and mutations in clinical genetic testing: haplotype-based testing and analysis

Area of Science:

• Genetics
• Bioinformatics
• Medical Genetics

Background:

• Haplotype analysis using high-density single nucleotide polymorphism (SNP) markers is increasingly important in clinical genetics.
• Haplotype information aids in predicting disease severity and prognosis for genetic disorders.
• Intragenic cis-interactions between polymorphisms and mutations influence disease phenotypes and penetrance.

Purpose of the Study:

• To highlight the utility of haplotype-based analysis in genetic research.
• To demonstrate the application of haplotype studies in understanding gene-gene interactions and disease mechanisms.
• To emphasize the potential of clinically relevant haplotypes in improving diagnosis and treatment strategies.

Main Methods:

• Utilizing high-density single nucleotide polymorphism (SNP) markers for haplotype construction.
• Applying knowledge-based approaches and linkage analyses with SNP-tagged haplotypes.
• Examining intragenic cis-interactions and gene-gene interactions in disease loci.

Main Results:

• Haplotype studies are effective in fine mapping complex diseases and identifying genetic variations affecting drug response.
• Studies on prion protein (PRNP) and cystic fibrosis transmembrane conductance regulator (CFTR) genes show influence on phenotypes and penetrance.
• Haplotype analyses in inflammatory bowel disease loci reveal complex gene-gene interactions impacting clinical outcomes.

Conclusions:

• Understanding clinically relevant haplotypes can significantly improve the diagnosis and treatment of both monogenic and polygenic diseases.
• Haplotype-based analysis is a powerful tool for dissecting genetic contributions to disease.
• Further research into haplotype-phenotypic characterizations is crucial for advancing personalized medicine.